We are excited to announce a $40 million strategic investment from @Sanofi $VIGL Read more: investors.vigilneuro.com/news-releases/…

$VIGL announces an update following a Type C Meeting with the FDA to our clinical development strategy for the IGNITE clinical trial evaluating iluzanebart in people living with ALSP. Please see our full press release for more information shorturl.at/MuKRz

This month the Vigil team celebrated our fourth anniversary! We are so proud of this team and all that we have accomplished together! #VigilantForYou

Today, $VIGL announced interim data from its ongoing Ph1 clinical trial evaluating VG-3927 in healthy volunteers supports continued development in #Alzheimers disease Full press release: investors.vigilneuro.com/news-events/ne…

Mark your calendars! – The Know Your Genes: Understanding Genetic Testing Webinar is this Thursday, Sept 12. Hosted by Sisters' Hope Foundation , register now to learn about the genetic inheritance of ALSP and the ALSPAware program. …stershopefoundation.zohobackstage.com/KnowYourGenesU…

$VIGL management will be participating in a fireside chat at the Cantor Global Healthcare Conference today at 9:45am Join here: wsw.com/webcast/cantor…

#ICYMI in July, peer-reviewed research reported new data on the prevalence of CSF1R gene variants. #ALSP is a rare genetic disease caused by a mutation in the CSF1R gene. #LeukodystrophyAwarenessMonth shorturl.at/jLgOt

Vigil is proud to recognize #WorldMentalHealthDay. To prioritize the well-being of our team, we have #SummerFridays, #NoMeetingFridays, a #FlexibleTimeOff policy & company-wide breaks while offering mindfulness workshops & access to resources like a meditation app #LifeAtVigil

Today is #InternationalDayOfTheGirl! Our team is passionate about empowering young women to pursue a career in science – that’s why our President & CEO Ivana Magovčević-Liebisch, PhD, JD created the Carolyn E. Green Scholarship. Learn more: bit.ly/3XOAjGH

Vigil is proud to recognize Indigenous Peoples’ Day as a company-wide holiday. Please join us in honoring Indigenous communities by learning about the history and culture of the Holiday: bit.ly/4d8tUKV

$VIGL recently published a manuscript detailing the impact of misdiagnosis on the #ALSP patient journey, which often involves a difficult and indirect path to diagnosis. Visit our website to learn more: vigilneuro.com/press-releases…

$VIGL News: Vigil Neuroscience reports third quarter 2024 financial results and provides business update. Learn more here: shorturl.at/wVQcK #Neuroscience #HarnesssingMicroglia

$VIGL News: Management participated in a fireside chat at the Guggenheim Global Healthcare Conference today. Watch the webcast here: investors.vigilneuro.com/news-events/ev…

Fear of judgment can keep people from seeking an Alzheimer’s diagnosis. By increasing awareness, we can fight the stigma and ensure those with AD receive proper care Learn more about early-stage support: bit.ly/3BJL3xH #AlzheimersAwarenessMonth

The Vigil team returned to Community Servings to prep & package medically-tailored, made-from-scratch meals for those impacted by chronic illnesses in MA & RI. Big thanks to Life Science Cares for introducing us to this great organization!

$VIGL News: Management will participate in a fireside chat at the Stifel 2024 Healthcare Conference later this afternoon. Watch the webcast here: investors.vigilneuro.com/news-events/ev…

$VIGL News: Management participated in a fireside chat at the Jefferies London Healthcare Conference earlier this morning. Watch the webcast here: investors.vigilneuro.com/news-events/ev…

DYK: increased levels of #TREM2 are associated with slower progression of Alzheimer’s? Using TREM2 to activate microglia mean using the brain’s immune system to fight neurodegeneration. Learn more about our approach: investors.vigilneuro.com/news-events/ev…

Learn more about biomarkers and their role in rare disease drug development: bit.ly/4fjcu05 #ALSP #Neuroscience #HarnessingMicroglia #VigilantForYou

#RareDiseaseDay: Listen to the latest episode of the In Sickness podcast. Ron and Marla, whose son lives with MLC, and VIGL leadership discuss the incorporation of the caregiver experience in drug development. Listen on most podcast platforms, or here: shorturl.at/k7ktR